Literature DB >> 2083856

Piezoelectric lithotripsy and soft tissue injury. Safety limits in the experimental and clinical setting.

A Darzi1, I Reid, E Kay, J R Monson, W A Tanner, F B Keane.   

Abstract

Controversy surrounds the capacity of extracorporeal shock wave lithotripsy to cause soft tissue injury. This study examines the influence of different dosages of shock waves on the gall bladder in both humans and an animal model. Sixty one guinea pigs were divided into groups and subjected to different numbers of shock waves (6,000, 24,000, and 48,000) at different frequencies (2.5, 5.0, 10, 20 shock waves per second) and sacrificed at different intervals. Soft tissue damage after lithotripsy seemed to be related to the number of shock waves administered. In addition, repeated administration of low dose lithotripsy (at weekly intervals for six weeks) did not seem to produce a cumulative injury. Finally, in the animals sacrificed one month after receiving high dose lithotripsy, no soft tissue damage was evident, indicating satisfactory healing. Thirty patients were subjected to either high dose (36,000 shock waves) or low dose (6,000 shock waves) lithotripsy 24 hours before elective cholecystectomy. Both macroscopic and microscopic evidence of soft tissue injury were detected in a significantly higher percentage of patients who received a high dose in a single treatment (p less than 0.05). The group who received repeated low dose lithotripsy showed no evidence of cumulative injury. We conclude that low dose lithotripsy produces minimal soft tissue injury and is safe when repeated up to six times at weekly intervals.

Entities:  

Mesh:

Year:  1990        PMID: 2083856      PMCID: PMC1378733          DOI: 10.1136/gut.31.10.1110

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  9 in total

1.  Extension of selection criteria for extracorporeal shock wave lithotripsy for gall stones.

Authors:  A Darzi; J R Monson; C O'Morain; W A Tanner; F B Keane
Journal:  BMJ       Date:  1989-07-29

2.  Extracorporeal shock wave lithotripsy: the first 50 patients treated in Britain.

Authors:  J E Wickham; D R Webb; S R Payne; M J Kellet; G Watkinson; H N Whitfield
Journal:  Br Med J (Clin Res Ed)       Date:  1985-04-20

3.  Acoustic cavitation generated by an extracorporeal shockwave lithotripter.

Authors:  A J Coleman; J E Saunders; L A Crum; M Dyson
Journal:  Ultrasound Med Biol       Date:  1987-02       Impact factor: 2.998

4.  Renal morphology and function immediately after extracorporeal shock-wave lithotripsy.

Authors:  J V Kaude; C M Williams; M R Millner; K N Scott; B Finlayson
Journal:  AJR Am J Roentgenol       Date:  1985-08       Impact factor: 3.959

5.  Shock waves for gallstones: animal studies.

Authors:  W Brendel; G Enders
Journal:  Lancet       Date:  1983-05-07       Impact factor: 79.321

6.  Shock-wave lithotripsy of gallbladder stones. The first 175 patients.

Authors:  M Sackmann; M Delius; T Sauerbruch; J Holl; W Weber; E Ippisch; U Hagelauer; O Wess; W Hepp; W Brendel
Journal:  N Engl J Med       Date:  1988-02-18       Impact factor: 91.245

7.  Evidence for ultrasonically induced cavitation in vivo.

Authors:  G R ter Haar; S Daniels
Journal:  Phys Med Biol       Date:  1981-11       Impact factor: 3.609

8.  Fragmentation of gallstones by extracorporeal shock waves.

Authors:  T Sauerbruch; M Delius; G Paumgartner; J Holl; O Wess; W Weber; W Hepp; W Brendel
Journal:  N Engl J Med       Date:  1986-03-27       Impact factor: 91.245

9.  Piezo-ceramic lithotripsy of gallbladder stones: initial experience in 38 patients.

Authors:  K A Hood; A Keightley; R H Dowling; J A Dick; C N Mallinson
Journal:  Lancet       Date:  1988-06-11       Impact factor: 79.321

  9 in total
  2 in total

Review 1.  General surgery.

Authors:  I Taylor
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

2.  The osteogenic potential of extracorporeal shock wave therapy. an in-vivo study.

Authors:  D McCormack; H Lane; J McElwain
Journal:  Ir J Med Sci       Date:  1996 Jan-Mar       Impact factor: 1.568

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.